Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2475-2479

  Ramage, G ^a   Vande Walle, K ^a   Wickes, B L ^a   Lopez Ribot J L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FORMAZAN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BIOASSAY; BIOFILM; CANDIDA ALBICANS; COLORIMETRY; MEASUREMENT; NONHUMAN; PHENOTYPE; PLANKTON; PRIORITY JOURNAL; REPRODUCIBILITY; STANDARDIZATION;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CELL COUNT; COLORIMETRY; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS;

EID: 0034863427     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2475-2479.2001     Document Type: Article

References (39)

1. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro
2. Candida biofilms and their susceptibility to antifungal agents
3. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents
4. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B
5. Centrifuges, colorimeters and bacterial counts
6. Oral colonization by Candida albicans
7. The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms
8. Cell wall and secreted proteins of Candida albicans: Identification, function, and expression
9. Immunologic aspects of oral candidiasis
10. Bacterial biofilms: A common cause of persistent infections
11. Intravascular catheter-associated infections
12. Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards
13. Candida 'the cancer of silastic.'
14. Standardization of antifungal susceptibility testing and clinical relevance
15. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: Effect of specific growth rate
16. Susceptibility of bacterial biofilms to tobramycin: Role of specific growth rate and phase in the division cycle
17. Bacterial biofilms: Resistance to antimicrobial agents
18. The development of a small-scale biofilm model suitable for studying the effects of antibiotics on biofilms of gram-negative bacteria
19. Susceptibility testing of fungi and correlation with clinical outcome
20. Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome
21. Influence of growth rate on susceptibility to antimicrobial agents: Biofilms, cell cycle, dormancy, and stringent response
22. Biofilm susceptibility to antimicrobials
23. In vitro development of Staphylococcus aureus biofilms using slime-producing variants and ATP-bioluminescence for automated bacterial quantification
24. Adhesive colonization of biomaterials and antibiotic resistance
25. Adhesion of different Candida spp. to plastic: XTT formazan determinations
26. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: A modified XTT tetrazolium assay using synchronised C. albicans cells
27. Resistance of Candida albicans biofilms to antifungal agents in vitro
28. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] -2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents
29. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin
30. Bacterial resistance to antibiotics: The role of biofilms
31. The biofilm glycocalyx as a resistance factor
32. Production of mucoid exopolysaccharide during development of Pseudomonas aeruginosa biofilms
33. Riddle of biofilm resistance
34. Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm
35. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections
36. Antimicrobial substances and effects on sessile bacteria
37. Biofilms
38. Innovative endpoint determination system for antifungal susceptibility testing of yeasts